Giulia Campoli

Limb-Girdle Muscular Dystrophies (LGMDs): The Clinical Application of NGS Analysis, a Family Case Report

G. Pagliaroli, S. Servidei, G. Minozzi, 2019, Front. Neurol..

The variability of SMCHD1 gene in FSHD patients: evidence of new mutations

E. Ricci, G. Novelli, G. Tasca, 2019, Human molecular genetics.

Genetic Counseling and NGS Screening for Recessive LGMD2A Families

S. Servidei, G. Minozzi, E. Giardina, 2020, High-throughput.

NGS Analysis for Molecular Diagnosis of Retinitis Pigmentosa (RP): Detection of a Novel Variant in PRPH2 Gene

G. Pagliaroli, G. Novelli, G. Minozzi, 2019, Genes.

Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era

G. Pagliaroli, S. Gambardella, E. Giardina, 2019, neurogenetics.

Genetic Variants Allegedly Linked to Antisocial Behaviour Are Equally Distributed Across Different Populations

C. Caltagirone, E. Giardina, C. Strafella, 2021, Journal of personalized medicine.

Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders

C. Caltagirone, G. Spalletta, L. Petrosini, 2021, Journal of personalized medicine.

Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era

S. Gambardella, E. Giardina, J. Mela, 2019, neurogenetics.